SOURCE: Eugene Science, Inc.

January 29, 2007 06:30 ET

Eugene Science Enters Into Contract With RexGene Biotech, One of Major Functional Manufacturers

LOS ANGELES, CA -- (MARKET WIRE) -- January 29, 2007 -- Eugene Science (OTCBB: EUSI), developer and marketer of advanced health supplements & nutraceutical products, entered into a contract with RexGene Biotech on January 3, 2007, to develop, produce and market a new type of health supplement product containing Eugene Science's exclusive CZ™ which cholesterol-lowering nutraceutical products. The two companies signed an MOU on November 2, 2006, prior to this official contract.

With this contract, Eugene Science will develop with RexGene Biotech various types of health supplements made of plant sterol and market raw materials and end products using RexGene Biotech's sales networks. RexGene Biotech has a strong sales network through network marketing (High-Living), Korea's largest drugstore chain (Onnuri), TV home shopping and collaborating pharmaceutical companies and recently completed healthy beverage production facility to expand its scope of business. Therefore, it would provide Eugene Science with various business opportunities to broaden and diversify raw material and end product markets.

Furthermore, Eugene Science's powerful technology and products, coupled with RexGene Biotech's global production facilities and collaborative marketing networks, would be able to open up new possibilities for Korea's health supplement market and respond to the stricter product quality control requirements of the Health Supplement Act.

RexGene Biotech is Korea's first venture company in health supplement industry to be enlisted in KOSDAQ and specializes in OEM and ODM businesses through its GMP facility for health supplements.

Eugene Science has been recognized for its exclusive technology to develop and use Plant Sterol and has concentrated on overseas marketing in the U.S., Japan, and Southeast Asia. Its marketing in Korea has begun when Plant Sterol was officially authorized as a type of health supplement in Korea.

With the recent contract, Eugene Science is expected to end the depression in Korea's health supplement market through its strategic partnership with RexGene Biotech, which is Korea's best health supplement producer and marketer.

About RexGene Biotech

For additional information about RexGene Biotech, please visit its website at http://www.RexGenebio.co.kr/english/home/main/Info.php?code=AA.

About Eugene Science

Based in Bucheon, Kyunggi-Do, Korea, Eugene Science is a global biotechnology company tackling ailments such as heart disease, obesity and diabetes through innovation in the nutraceutical field. Its first commercial heart disease product, CZ™, is a patented, nanoscience-based, water-soluble functional food ingredient containing natural plant sterols that help maintain healthy cholesterol levels by inhibiting its absorption. CZ™ is available in capsule form, or as a food or beverage additive. These plant sterols are approved by the U.S. FDA for health claims related to cholesterol lowering efficacy. Please visit www.eugene21.com.

Contact Information

  • Investor Relations:

    Mirador Consulting, Inc.
    Rich Miller
    (561) 989-3600

    Capital Group Communications
    Richard Carpenter or Mark Bernhard
    email: Email Contact
    (415) 332-7200